{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:34:37Z","timestamp":1772825677426,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2020,8,25]]},"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To compare the whole genomes sequencing (WGS) results in the 100K Genomes project with the results of routine molecular diagnostics in precision medicine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and methods<\/jats:title>\n                  <jats:p>We analysed 374 cancers including a high tumour mutational burden (TMB-high) subgroup, defined as &gt;10 non-synonymous single nucleotide variations per megabase. Colon cancers were evaluated for microsatellite instability (MSI), mismatch repair (MMR) genes and NRAS, KRAS and BRAF mutations using routine molecular diagnostics. Fluorescence in-situ hybridisation\/immunohistochemistry was used to evaluate the Her2Neu status in breast cancers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There was high correlation between WGS and routine diagnostic testing results irrespective of TMB status in colon cancers. Her2Neu status was discordant in 3 out of the 5 TMB-high breast cancers (p=0.049). The presence of ductal carcinoma in-situ correlated significantly with discordance (p=0.04). There were 3 (5%) discordant colorectal cases, all in the KRAS gene, 2 of which were from the non-invasive adenomatous component (p=0.0058). Of the 374 cases we identified 24 tumours with a TMB &gt;10; comprising (colorectal carcinomas (CRCs) n=16, breast carcinomas n=5, bladder urothelial cell cancers n=3). Of the 16 TMB-high colorectal adenocarcinomas, 13 had MSI-high status. The same 13 had defective MMR protein expression. TMB-high colorectal cancers had 100% concordant results between WGS and NGS testing for KRAS, BRAF and NRAS (16\/16).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The microsatellite and mutational status of colorectal cancers evaluated by WGS seem to correlate well with the routine diagnostic testing if it is ensured that the invasive component is sequenced. Evaluation of WGS results need to be carefully correlated with histomorphology, as tumour heterogeneity\/contamination with pre-malignant components needs to be taken into account.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jclinpath-2020-206998","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T17:20:44Z","timestamp":1603992044000},"page":"718-723","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Validity of whole genomes sequencing results in neoplasms in precision medicine"],"prefix":"10.1136","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-9302","authenticated-orcid":false,"given":"Godwins","family":"Echejoh","sequence":"first","affiliation":[{"name":"Department of Histopathology, King\u2019s College Hospital, King\u2019s College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Histopathology, King\u2019s College Hospital, King\u2019s College, London, UK"},{"name":"Advanced Diagnostics, Department of Histopathology, Tissue Sciences, Viapath, King\u2019s College Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Chung-Faye","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, King\u2019s College Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Charlton","sequence":"additional","affiliation":[{"name":"Precision Medicine, King\u2019s College Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Moorhead","sequence":"additional","affiliation":[{"name":"Department of Histopathology, King\u2019s College Hospital, King\u2019s College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barnaby","family":"Clark","sequence":"additional","affiliation":[{"name":"Precision Medicine, King\u2019s College Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Davidson","sequence":"additional","affiliation":[{"name":"Precision Medicine, King\u2019s College Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debashis","family":"Sarker","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Guy\u2019s and St Thomas\u2019 NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Guy\u2019s and St Thomas\u2019 NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Lucas","family":"Ooft","sequence":"additional","affiliation":[{"name":"Department of Histopathology, King\u2019s College Hospital, King\u2019s College, London, UK"},{"name":"School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"key":"2025092504274210000_74.11.718.1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12222"},{"key":"2025092504274210000_74.11.718.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191367098"},{"key":"2025092504274210000_74.11.718.3","doi-asserted-by":"publisher","DOI":"10.1038\/nature12624"},{"key":"2025092504274210000_74.11.718.4","doi-asserted-by":"publisher","DOI":"10.1038\/nature10762"},{"key":"2025092504274210000_74.11.718.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2009.11.002"},{"key":"2025092504274210000_74.11.718.6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2339"},{"key":"2025092504274210000_74.11.718.7","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00085","article-title":"Overview on clinical relevance of intra-tumor heterogeneity","volume":"5","author":"Stanta","year":"2018","journal-title":"Front Med"},{"key":"2025092504274210000_74.11.718.8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44745"},{"key":"2025092504274210000_74.11.718.9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00428-016-1987-9","article-title":"Tumour heterogeneity: principles and practical consequences","volume":"469","author":"Stanta","year":"2016","journal-title":"Virchows Arch"},{"key":"2025092504274210000_74.11.718.10","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"2025092504274210000_74.11.718.11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200102223440801","article-title":"Gene-Expression profiles in hereditary breast cancer","volume":"344","author":"Hedenfalk","year":"2001","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025092504274210000_74.11.718.12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-3-319-13957-9_4","article-title":"Tissue heterogeneity as a pre-analytical source of variability","volume":"199","author":"Stanta","year":"2015","journal-title":"Recent Results Cancer Res"},{"key":"2025092504274210000_74.11.718.13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jamaoncol.2015.3638","article-title":"Quantitative assessment of the heterogeneity of PD-L1 expression in non-small-cell lung cancer","volume":"2","author":"McLaughlin","year":"2016","journal-title":"JAMA Oncol"},{"key":"2025092504274210000_74.11.718.14","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-020-0927-9","article-title":"Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment","volume":"15","author":"Krieger","year":"2020","journal-title":"Diagn Pathol"},{"key":"2025092504274210000_74.11.718.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2019.12.010"},{"key":"2025092504274210000_74.11.718.16","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2014-202571"},{"key":"2025092504274210000_74.11.718.17","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2011-200265"},{"key":"2025092504274210000_74.11.718.18","doi-asserted-by":"crossref","unstructured":"Lai Z , Markovets A , Ahdesmaki M , et al . VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res 2016;44:e108.","DOI":"10.1093\/nar\/gkw227"},{"key":"2025092504274210000_74.11.718.19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0454-7"},{"key":"2025092504274210000_74.11.718.20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.celrep.2016.06.026","article-title":"Kataegis expression signature in breast cancer is associated with late onset, better prognosis, and higher HER2 levels","volume":"16","author":"D'Antonio","year":"2016","journal-title":"Cell Rep"},{"key":"2025092504274210000_74.11.718.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616288"},{"key":"2025092504274210000_74.11.718.22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41416-019-0436-3","article-title":"The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution","volume":"120","author":"Miligy","year":"2019","journal-title":"Br J Cancer"},{"key":"2025092504274210000_74.11.718.23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.12809\/hkmj144458","article-title":"Comparison of fluorescence in-situ hybridisation with dual-colour in-situ hybridisation for assessment of HER2 gene amplification of breast cancer in Hong Kong","volume":"22","author":"Tang","year":"2016","journal-title":"Hong Kong Med J"},{"key":"2025092504274210000_74.11.718.24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.064"},{"key":"2025092504274210000_74.11.718.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.10.006"},{"key":"2025092504274210000_74.11.718.26","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0519"},{"key":"2025092504274210000_74.11.718.27","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.69"},{"key":"2025092504274210000_74.11.718.28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00428-015-1748-1","article-title":"In stage II\/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival","volume":"466","author":"Bonin","year":"2015","journal-title":"Virchows Arch"},{"key":"2025092504274210000_74.11.718.29","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-017-2886-0","article-title":"Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases","volume":"10","author":"Rausch","year":"2017","journal-title":"BMC Res Notes"},{"key":"2025092504274210000_74.11.718.30","first-page":"735","article-title":"Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives","volume":"16","author":"Battaglin","year":"2018","journal-title":"Clin Adv Hematol Oncol"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2020-206998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:27:57Z","timestamp":1758799677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2020-206998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,10,19]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/jclinpath-2020-206998"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2020-206998","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]}}}